Despite all challenges and roadblocks, the field of cancer biomarker research continues to advance, with ongoing efforts to discover and validate new biomarkers. As technology improves and our understanding of cancer biology deepens, the potential for earlier and more accurate cancer diagnosis becomes increasingly achievable. These efforts have the potential to significantly reduce cancer-related morbidity and mortality in the future.